NCTC
ABBV icon

New Covenant Trust Company’s AbbVie ABBV Stock Holding History

New Covenant Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$573K Buy
2,276
+189
+9% +$40.7K 0.43% 41
2026
Q1 		$454K Buy
2,087
+484
+30% +$107K 0.41% 40
2025
Q4 		$368K Buy
1,603
+19
+1% +$4.33K 0.33% 45
2025
Q3 		$367K Sell
1,584
-17
-1% -$3.46K 0.34% 45
2025
Q2 		$292K Sell
1,601
-9
-0.6% -$1.67K 0.26% 56
2025
Q1 		$331K Sell
1,610
-122
-7% -$23.7K 0.35% 50
2024
Q4 		$305K Sell
1,732
-70
-4% -$12.9K 0.3% 52
2024
Q3 		$351K Sell
1,802
-16
-0.9% -$2.99K 0.34% 46
2024
Q2 		$313K Sell
1,818
-110
-6% -$18.2K 0.36% 46
2024
Q1 		$351K Buy
+1,928
New +$332K 0.35% 40

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

New Covenant Trust Company's ABBV Position: Q2 2026 in Review

New Covenant Trust Company increased its AbbVie (ABBV) stake by 9.1% in Q2 2026, buying an estimated $40.7K and bringing the position to 2,276 shares worth $573K. The position accounts for 0.43% of the portfolio, ranked #41.

New Covenant Trust Company first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • New Covenant Trust Company held 2,276 shares of AbbVie worth $573K as of Q2 2026.
  • New Covenant Trust Company bought 189 AbbVie shares in Q2 2026, an estimated $40.7K.
  • AbbVie made up 0.43% of New Covenant Trust Company's portfolio in Q2 2026, its #41 holding.
  • New Covenant Trust Company first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.